Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI

European Radiology

Volumn 23, Issue 1, 2013, Pages 37-47

  Marinescu, Marilena ^a   Chauveau, Fabien ^a,b   Durand, Anne ^a,b   Riou, Adrien ^a,b   Cho, Tae Hee ^a,b   Dencausse, Anne ^c   Ballet, Sébastien ^c   Nighoghossian, Norbert ^a,b   Berthezène, Yves ^a,b   Wiart, Marlène ^a  

^a UNIVERSITÉ DE LYON   (France)

^b CNRS   (France)

^c Laboratoire Guerbet   (France)

Author keywords

Cerebral ischaemia; Inflammation; MRI; Treatment monitoring; USPIO

Indexed keywords

IRON; MINOCYCLINE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN LEVEL; BRAIN TISSUE; CADAVER; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THERAPY EFFECT;

ANALYSIS OF VARIANCE; ANIMALS; CONTRAST MEDIA; DEXTRANS; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MINOCYCLINE; STROKE;

EID: 84871330189     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2567-2     Document Type: Article

References (32)

1. Adams HP Jr, del Zoppo G, Alberts MJ et al (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655-1711 (Pubitemid 46691097)
2. Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317-1329
3. Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127-136 (Pubitemid 36176947)
4. Durukan A, Tatlisumak T (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87:179-197 (Pubitemid 46860315)
5. Corot C, Petry KG, Trivedi R et al (2004) Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 39:619-625 (Pubitemid 39287601)
6. Chauveau F, Cho TH, Berthezene Y, Nighoghossian N, Wiart M (2011) Imaging inflammation in stroke using magnetic resonance imaging. Int J Clin Pharmacol Ther 48:718-728
7. Nighoghossian N, Wiart M, Cakmak S et al (2007) Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 38:303-307 (Pubitemid 46184299)
8. Bernd H, De Kerviler E, Gaillard S, Bonnemain B (2009) Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program. Invest Radiol 44:336-342
9. Emsley HC, Tyrrell PJ (2002) Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 22(12):1399-1419 (Pubitemid 35424925)
10. Planas AM, Traystman RJ (2010) Advances in translational medicine. Stroke 42:283-284
11. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96:13496-13500
12. Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H (2005) Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res 1044:8-15 (Pubitemid 40616047)
13. Machado LS, Sazonova IY, Kozak A et al (2009) Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke 40:3028-3033
14. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH (2008) Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 39:3372-3377
15. Chauveau F, Moucharrafie S, Wiart M et al (2011) In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure. Exp Transl Stroke Med 2:4
16. Pialat JB, Cho TH, Beuf O et al (2007) MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice. NMR Biomed 20:335-342 (Pubitemid 46824533)
17. Andes D, Craig WA (2002) Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents 19:261-268 (Pubitemid 34308974)
18. Homsi S, Federico F, Croci N et al (2009) Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res 1291:122-132
19. Desestret V, Brisset JC, Moucharrafie S et al (2009) Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Stroke 40:1834-1841
20. Rausch M, Sauter A, Frohlich J, Neubacher U, Radu EW, Rudin M (2001) Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 46:1018-1022 (Pubitemid 33019928)
21. Wiart M, Davoust N, Pialat JB et al (2007) MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke 38:131-137 (Pubitemid 46035618)
22. Franklin (1997) The Mouse Brain In Stereotaxic Coordinates(ed) (eds) San Diego, Calif:Academic Press
23. Brisset JC, Sigovan M, Chauveau F et al (2011) Quantification of iron-labeled cells with positive contrast in mouse brains. Mol Imaging Biol 13:672-678
24. Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG (2006) Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37:1087-1093
25. Martin A, Boisgard R, Kassiou M, Dolle F, Tavitian B (2010) Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714. Mol Imaging Biol
26. Fisher M, Feuerstein G, Howells DW et al (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40:2244-2250
27. Fagan SC, Waller JL, Nichols FT et al (2010) Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 41:2283-2287
28. Rausch M, Baumann D, Neubacher U, Rudin M (2002) In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 15:278-283 (Pubitemid 34716324)
29. Stroh A, Zimmer C, Werner N et al (2006) Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging. NeuroImage 33:886-897 (Pubitemid 44739995)
30. Brisset JC, Desestret V, Marcellino S et al (2009) Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 T. Eur Radiol 20:275-285
31. Sigovan M, Boussel L, Sulaiman A, et al. (2009) Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 252:401-409
32. Fisher M, Davalos A, Rogalewski A, Schneider A, Ringelstein EB, Schabitz WR (2006) Toward a multimodal neuroprotective treatment of stroke. Stroke 37:1129-1136